NCT07524569

Brief Summary

The aim of this study is to compare the effects of digital intraosseous anesthesia and manual intraligamentary anesthesia techniques on pain scores during the restorative treatment of permanent mandibular molars in pediatric patients. In addition, the techniques will be compared in terms of injection pain, anesthetic success, postoperative complications, and patient preferences. This randomized, controlled, crossover, single-blind, split-mouth study will be conducted on 78 children aged 6-12 years. Participants with bilateral permanent mandibular molars presenting enamel-dentin carious lesions will be included in the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Apr 2026Oct 2027

First Submitted

Initial submission to the registry

March 24, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

March 24, 2026

Last Update Submit

April 5, 2026

Conditions

Keywords

intraligamentary anesthesiapaediatric dentistryDigital Intraosseous Anesthesia

Outcome Measures

Primary Outcomes (6)

  • Pain intensity using Visual Analog Scale (VAS)

    Subjective pain perception measured using a 0-10 Visual Analog Scale (0 = no pain, 10 = worst possible pain). Pain is assessed during injection and during dental treatment.

    During injection and during dental procedure

  • Pain intensity using Wong-Baker FACES Pain Rating Scale

    Subjective pain perception measured using the Wong-Baker FACES Pain Rating Scale (0-10), where higher scores indicate greater pain. Pain is assessed during injection and during dental treatment.

    During injection and during dental procedure

  • Heart rate changes

    Heart rate measured using a pulse oximeter (beats per minute, bpm).

    Baseline, during injection and during dental procedure

  • Oxygen saturation (SpO₂) changes

    Arterial oxygen saturation measured using a pulse oximeter (%).

    Baseline, during injection and during dental procedure

  • Practitioner's assessment of anesthesia success

    Clinician-reported outcomes including need for additional anesthesia, presence of discomfort during treatment, and successful completion of the procedure without pain.

    Immediately after dental treatment

  • Postoperative complications

    Presence of postoperative complications related to local anesthesia.

    Day 1 after intervention

Secondary Outcomes (1)

  • Correlation between pain scores measured by VAS and Wong-Baker FACES scale

    Immediately after injection

Study Arms (2)

Intraligamentary Anaesthesia

EXPERIMENTAL

Before the restorative treatment of mandibular first molar, SOPIRA® 30 gauge extra-short cartridge needle attached to the tip of the SOPIRA® Citoject (SOPIRA® Heraeus Kulzer, Hanau, Almanya) pressure injector will be inserted into the periodontal sulcus 1-2 mm until resistance. The needle will be at an angle of 30 degrees to the long axis of the tooth. As recommended by the manufacturer, a total of 0.36 ml (mesiobuccal and distobuccal) 4% articaine solution containing 1:100,000 epinephrine (Ultracaine DS forte cartridge, Sanofi-Aventis GmbH, Almanya) will be injected slowly over 42 seconds by pressing the dosing lever 3 times for each root. If the anaesthesia will be failed, we would use the 4-point IL injection by injecting the mesiolingual sulcus and distolingual sulcus with the same technique.

Procedure: Intraligamentary anaesthesia

Digital Intraosseous Anesthesia

ACTIVE COMPARATOR

For the digital intraosseous anesthesia technique, the handpiece will be stabilized by holding it as close to the needle as possible and maintaining firm support on the device holder to ensure maximum precision. To enhance the accuracy of movements, stable intraoral finger rests will be used throughout the procedure. The Effitec needle will be positioned at the papillary apex and oriented toward the area between the apices of the two adjacent teeth. To maintain correct needle positioning and prevent rotational movement, the handpiece will be held nearly parallel to the gingival tissues. Penetration will be directed toward the center of the interdental septum. When the needle enters the cancellous bone, a characteristic sensation similar to cracking an eggshell may be perceived. Before initiating the injection, the needle will be slightly withdrawn to ensure proper placement and avoid excessive penetration.

Procedure: Digital Intraosseous Anesthesia

Interventions

Anesthesia One tooth anaesthesia by 2 or 4 points intraligamentary injection

Also known as: 2 or 4 points intraligamentary injection
Intraligamentary Anaesthesia

Anesthesia for one tooth using computer-controlled single-point injection into cancellous bone

Digital Intraosseous Anesthesia

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Subjects with American Society of Anesthesiologists score I (ASA I)
  • Subjects with Frankl's behavior rate III (positive) and IV (definitely positive),
  • Subjects with indication of similar restoration treatment on bilateral first -permanent mandibular molars
  • Subjects whose plaque index score of 0 (no plaque) and 1
  • Subjects whose gingival index score of 0

You may not qualify if:

  • Allergic to the local anesthetics or sulfites
  • Subjects with cholinesterase deficiency
  • Subjects who use drugs that may affect the assessment of pain, such as narcotic or non-narcotic analgesic, anti-inflammatory, anxiolytic, antipsychotic and antihistamine agents
  • Subjects who need to use sedatives or other medications during dental procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Katip Çelebi University Faculty of Dentistry

Izmir, Cigli, 35000, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Funda Çağırır Dindaroğlu, Study Director

CONTACT

Buse Düzgün, Principal Investigator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization was performed by a computer-generated random sorting sequence
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized controlled, single-blind, split-mouth clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Dr.

Study Record Dates

First Submitted

March 24, 2026

First Posted

April 13, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations